Genexine Market Cap

Genexine has a market cap or net worth of 292.89 billion as of July 18, 2025. Its market cap has increased by 8.21% in one year.

Market Cap

292.89B

Enterprise Value

309.05B

Revenue

5.81B

Ranking

n/a

PE Ratio

n/a

Stock Price

6,440.00

Market Cap Chart

Since September 15, 2009, Genexine's market cap has increased from 109.02B to 292.89B, an increase of 168.66%. That is a compound annual growth rate of 6.43%.

Market Cap History

Date	Market Cap	% Change
Jul 18, 2025	292.89B	20.60%
Dec 30, 2024	242.86B	-40.82%
Dec 28, 2023	410.35B	-12.73%
Dec 29, 2022	470.21B	-67.78%
Dec 30, 2021	1,459.20B	-52.47%
Dec 30, 2020	3,069.93B	106.72%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	74.80T
Celltrion	39.82T
ALTEOGEN	26.19T
Yuhan	9,866.54B
SK Biopharmaceuticals	8,066.26B
HLB Co., Ltd.	6,939.04B
Peptron	6,861.07B
PharmaResearch	5,890.93B

Market Cap Rankings